BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29324345)

  • 1. Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect.
    Xu M; Wang Y; Yang F; Wu C; Wang Z; Ye B; Jiang X; Zhao Q; Li J; Liu Y; Zhang J; Tian G; He Y; Shen J; Jiang H
    Eur J Med Chem; 2018 Feb; 145():74-85. PubMed ID: 29324345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics.
    Xiamuxi H; Wang Z; Li J; Wang Y; Wu C; Yang F; Jiang X; Liu Y; Zhao Q; Chen W; Zhang J; Xie Y; Hu T; Xu M; Guo S; Akber Aisa H; He Y; Shen J
    Bioorg Med Chem; 2017 Sep; 25(17):4904-4916. PubMed ID: 28774576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure-activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics.
    Yang F; Jiang X; Li J; Wang Y; Liu Y; Bi M; Wu C; Zhao Q; Chen W; Yin J; Zhang J; Xie Y; Hu T; Xu M; Guo S; Wang Z; He Y; Shen J
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3141-3147. PubMed ID: 27173799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychotics.
    Xu M; Guo S; Yang F; Wang Y; Wu C; Jiang X; Zhao Q; Chen W; Tian G; Zhu F; Xie Y; Hu T; Wang Z; He Y; Shen J
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800306. PubMed ID: 30702760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological characterization of novel N-(trans-4-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics.
    Chen XW; Sun YY; Fu L; Li JQ
    Eur J Med Chem; 2016 Nov; 123():332-353. PubMed ID: 27487565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.
    Xu M; Wang Y; Yang F; Wu C; Wang Z; Ye B; Jiang X; Zhao Q; Li J; Liu Y; Zhang J; Tian G; He Y; Shen J; Jiang H
    Bioorg Med Chem Lett; 2018 Feb; 28(4):606-611. PubMed ID: 29395980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Biological Investigation of Flavone Derivatives as Potential Multi-Receptor Atypical Antipsychotics.
    Gao L; Yang Z; Xiong J; Hao C; Ma R; Liu X; Liu BF; Jin J; Zhang G; Chen Y
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoquinolinone derivatives as potent CNS multi-receptor D
    Jin J; Zhang K; Dou F; Hao C; Zhang Y; Cao X; Gao L; Xiong J; Liu X; Liu BF; Zhang G; Chen Y
    Eur J Med Chem; 2020 Dec; 207():112709. PubMed ID: 32877805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
    Norman MH; Rigdon GC; Navas F; Cooper BR
    J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
    Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
    J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel antipsychotic trans-4-(2-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)ethyl)cyclohexan-1-amine derivatives targeting dopamine/serotonin receptor subtypes.
    Xu JW; Qi YL; Wu JW; Yuan RX; Chen XW; Li JQ
    Bioorg Med Chem Lett; 2021 Jan; 31():127681. PubMed ID: 33189775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics.
    Chen Y; Wang S; Xu X; Liu X; Yu M; Zhao S; Liu S; Qiu Y; Zhang T; Liu BF; Zhang G
    J Med Chem; 2013 Jun; 56(11):4671-90. PubMed ID: 23675993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
    Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects.
    Zajdel P; Kos T; Marciniec K; Satała G; Canale V; Kamiński K; Hołuj M; Lenda T; Koralewski R; Bednarski M; Nowiński L; Wójcikowski J; Daniel WA; Nikiforuk A; Nalepa I; Chmielarz P; Kuśmierczyk J; Bojarski AJ; Popik P
    Eur J Med Chem; 2018 Feb; 145():790-804. PubMed ID: 29407591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of piperidine (piperazine)-amide substituted derivatives as multi-target antipsychotics.
    Huang L; Gao L; Zhang X; Yin L; Hu J; Song T; Chen Y
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127506. PubMed ID: 32828898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
    Rasmussen K; Benvenga MJ; Bymaster FP; Calligaro DO; Cohen IR; Falcone JF; Hemrick-Luecke SK; Martin FM; Moore NA; Nisenbaum LK; Schaus JM; Sundquist SJ; Tupper DE; Wiernicki TR; Nelson DL
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1265-77. PubMed ID: 16141369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of piperidine (piperazine)-substituted benzoxazole derivatives as multi-target antipsychotics.
    Huang L; Zhang W; Zhang X; Yin L; Chen B; Song J
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5299-305. PubMed ID: 26483200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Biological Evaluation of Five-Atom-Linker-Based Arylpiperazine Derivatives with an Atypical Antipsychotic Profile.
    Wu C; Wang Y; Yang F; Shi W; Wang Z; He L; He Y; Shen J
    ChemMedChem; 2019 Dec; 14(24):2042-2051. PubMed ID: 31746558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.